Role of cytokines in the syndrome of heart failure.
Sasayama
S
S
Department of Cardiovascular Medicine, Kyoto University.
Matsumori
A
A
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000676:Amrinone / Q000627:therapeutic use; D000818:Animals; D002316:Cardiotonic Agents / Q000627:therapeutic use; D016207:Cytokines / Q000502:physiology*; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D007694:Killer Cells, Natural; D009205:Myocarditis / Q000503:physiopathology; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011719:Pyrazines; D011804:Quinolines / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D016207:Cytokines; D010726:Phosphodiesterase Inhibitors; D011719:Pyrazines; D011804:Quinolines; D014409:Tumor Necrosis Factor-alpha; C041667:vesnarinone; D000676:Amrinone